Researchers examined the level of Del-1 in the plasma and circulating extracellular vesicles (EVs) of early stage breast cancer patients and found that the levels of Del-1 were upregulated both in the plasma and EVs compared to those of the controls. Here, EDIL3 is linked to breast carcinoma.